Tadalafil powder 171596-29-5 CAS NO.171596-29-5
- FOB Price: USD: 360.00-360.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Available Specifications:
USP(25-50)Kilogram
- Product Details
Keywords
- Tadalafil
- Tadalafei powder
- 171596-29-5
Quick Details
- ProName: Tadalafil powder 171596-29-5
- CasNo: 171596-29-5
- Molecular Formula: C22H19N3O4
- Appearance: White or almost white powder
- Application: Tadalafil is a PDE5 inhibitor for tre...
- DeliveryTime: 1-3 days
- PackAge: 1kg/bag, 5kg/bag, 25kg/drum
- Port: shanghai
- ProductionCapacity: 1000 Kilogram/Month
- Purity: 99.55%
- Storage: >2 years at -20 C
- Transportation: Ordinary and safe chemical, suggestion...
- LimitNum: 1 Kilogram
- Related Substances: ≤2%
- Residue on Ignition: 0.06%
- Heavy Metal: <8mg/kg
- Valid Period: 2 years
- purity: 99.55%
Superiority
Details
【Product name】Tadalafil powder
【CAS No.】171596-29-5
【Mol. Formula】C22H19N3O4
【Molecular Weight】389.40
【Assay】98.0%min
【Appearance】White or almost white powder
【Packing】25kg/drum or at customer's request.
【Storage】Tight container, protect from light
Quality Standard
Items | Specification |
Appearance | White or almost white powder |
Solubility | Practically insoluble in water, freely soluble in dimethyl sulfoxide, slightly soluble in methylene chloride |
Identification | IR,UV |
Special optical rotation (dried substance) | 78.0 to +84.0 |
Impurities A, B and C | Impurity A: ≤0.15% |
Specified impurities: ≤0.10% | |
relative substance | Unspecified impurities: ≤0.10% |
Total impurity: ≤0.3% | |
Loss on drying | ≤0.5% |
Sulfated ash | ≤0.1% |
Assay (on dried basis) | 97.5%~102% |
【Functions】
Tadalafil is a PDE5 inhibitor for treating erectile dysfunction
Tadalafil is for the treatment of Pulmonary arterial hypertension
Disorders of Sexual Function and Reproduction.
Treatment of, ENDOCRINE DRUGS, RENAL-UROLOGIC DRUGS
Treatment of Diabetic Complications
Treatment of Erectile Dysfunction
Treatment of Female Sexual Dysfunction
Treatment of Male Sexual Dysfunction, Phosphodiesterase V (PDE5A) Inhibitors